Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Leydig cell tumors can cause high testosterone in women and are treated by removing the ovaries.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Thorough evaluations and conservative management can lead to positive outcomes in pediatric adrenocortical carcinoma.

Cetuximab can cause unusual hair growth and hair loss.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

The study found a unique vein pattern around the aorta and two arteries in the right kidney.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Screen young women with menstrual issues, acne, or excess hair for high cortisol to avoid misdiagnosis.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.